#outlook-therapeutics
Latest news and interesting information about outlook-therapeutics.
Outlook Therapeutics director buys $176K in stock
Outlook Therapeutics director Kurt J. Hilzinger bought 400,000 shares worth $176,520. The stock is up 46.6% in the past week.
...
